Today's discussion on unraveling BPC 157 Peptide
Infinity Peptides
Show overview
Today's discussion on unraveling BPC 157 Peptide launched in 2025 and has put out 81 episodes in the time since. That works out to roughly 25 hours of audio in total. Releases follow a weekly cadence.
Episodes typically run ten to twenty minutes — most land between 12 min and 23 min — though episode length varies meaningfully from one episode to the next. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Science show.
The show is actively publishing — the most recent episode landed 4 days ago, with 19 episodes already out so far this year. The busiest year was 2025, with 62 episodes published. Published by Infinity Peptides.
From the publisher
We will discuss the preclinical trial information on Bpc157 what have we heard what have we experienced, along with where does it come from.‘RSSVERIFY’
Latest Episodes
View all 81 episodesFOXO4-DRI: The Science and Hype of Senolytic Peptides
Cerebrolysin: Clinical Science and Biohacking Analysis
ADAMAX Peptide: Science, Hype, and Cognitive Potential
Survodutide: The Metabolic Power of Dual Receptor Agonism
DT-109: The Tripeptide Frontier of Metabolic Health
Dihexa: Rewiring the Brain
ARA-290: The Science of Regenerative Nerve Repair
GHK-Cu: The Science of the Copper Peptide
NAD+ and Epitalon: The Longevity Stack
The secret Hollywood stack
Selank: The Russian Peptide for Calm Focus and Neuroplasticity
MOTS-c, a unique peptide encoded within mitochondrial DNA
Ep 65SS-31 and the Architecture of Mitochondrial Medicine
Super charging the mitochondria and this is already approved for Bart's disease along heart disease and other health issues.
Ep 64Snap-8 Science: A Deep Dive into Peptide Power
We will discuss the Dalton rate and everything in between.
Ep 63FST-344: Scientific Foundations and Therapeutic Potential
FST-344: Scientific Foundations and Therapeutic Potential that can unlock unlimited potential
Ep 62Tesofensine: The Neurochemical Frontier of Weight Management
Tesofensine the dementia possibility drug turns into a weight loss product!
Ep 61TB500 more updated information for possible healing
Let's talk about hype.and science for tb500
Ep 60“Immune Modulation Unpacked: The Science of Thymosin Alpha-1”
An evidence-based breakdown of Thymosin Alpha-1 (TA-1) covering immune mechanisms, preclinical research, human clinical trials, safety data, and ongoing studies in infection, sepsis, and cancer.
Ep 59Tesamorelin from bench to bedside FDA approval
This episode is designed for listeners interested in clinical research, peptide science, endocrinology, and translational medicine, offering an evidence-based perspective without speculation or medical advice.Topics include:Tesamorelin peptide mechanism of actionPreclinical and animal studiesPhase II and Phase III clinical trial dataFDA approval and HIV-associated lipodystrophyGrowth hormone, IGF-1, and metabolic effectsSafety, limitations, and ongoing research
Ep 58Growth hormone secretagogue cjc1295 and Ipamorelin
This episode is designed for listeners interested in clinical research, peptide science, endocrinology, and translational medicine, offering an evidence-based perspective without speculation or medical advice.Topics include:Tesamorelin peptide mechanism of actionPreclinical and animal studiesPhase II and Phase III clinical trial dataFDA approval and HIV-associated lipodystrophyGrowth hormone, IGF-1, and metabolic effectsSafety, limitations, and ongoing research